Reversal of TNP-470-induced endothelial cell growth arrest by guanine and guanine nucleosides

Journal of Pharmacology and Experimental Therapeutics

Volumn 334, Issue 3, 2010, Pages 729-738

  Hines, John ^a   Ju, Rong ^a   Dutschman, Ginger E ^b   Cheng, Yung Chi ^b   Crews, Craig M ^a,b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE; FORODESINE; FUMAGILLOL CHLOROACETYLCARBAMATE; GUANINE; GUANOSINE; METHIONYL AMINOPEPTIDASE 2; MYCOPHENOLIC ACID; PROTEIN P21; THYMIDINE; URIDINE; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC ANTIBIOTIC; CYCLOHEXANE DERIVATIVE; GUANINE NUCLEOTIDE; O-(CHLOROACETYLCARBAMOYL)FUMAGILLOL; P21 ACTIVATED KINASE; PROTEIN P53; SESQUITERPENE;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CYTOSTASIS; DRUG ANTAGONISM; ENDOTHELIUM CELL; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SYNTHESIS; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BOVINAE; CELL CYCLE; DRUG EFFECTS; ENZYME INDUCTION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; MOUSE; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; CATTLE; CELL CYCLE; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXANES; ENDOTHELIAL CELLS; ENZYME INDUCTION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GUANINE; GUANINE NUCLEOTIDES; MICE; MYCOPHENOLIC ACID; P21-ACTIVATED KINASES; SESQUITERPENES; THYMIDINE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77956245266     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.169110     Document Type: Article

References (38)

1. Ahumada A, Slusarski DC, Liu X, Moon RT, Malbon CC, and Wang HY (2002) Signaling of rat Frizzled-2 through phosphodiesterase and cyclic GMP. Science 298:2006-2010.
2. 1 integrin. J Cell Biol 166:97-109.
3. Brdlik CM and Crews CM (2004) A single amino acid residue defines the difference in ovalicin sensitivity between type 1 and type 2 methionine aminopeptidases. J Biol Chem 279:9475-9480.
4. Bronder JL and Moran RG (2003) A defect in the p53 reponse pathway induced by de novo purine synthesis inhibition. J Biol Chem 278:48861-48871.
5. Cherwinski HM, Cohn RG, Cheung P, Webster DJ, Xu YZ, Caulfield JP, Young JM, Nakano G, and Ransom JT (1995) The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis. J Pharmacol Exp Ther 275:1043-1049.
6. Chong CR, Qian DZ, Pan F, Wei Y, Pili R, Sullivan DJ Jr, and Liu JO (2006) Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target. J Med Chem 49:2677-2680.
7. Cirone P, Lin S, Griesbach HL, Zhang Y, Slusarski DC, and Crews CM (2008) A role for planar cell polarity signaling in angiogenesis. Angiogenesis 11:347-360.
8. Dubey RK, Gillespie DG, and Jackson EK (2002) A(2B) adenosine receptors stimulate growth of porcine and rat arterial endothelial cells. Hypertension 39:530-535.
9. Gervaz P, Scholl B, Padrun V, and Gillet M (2000) Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470. Liver 20:108-113.
10. Griffith EC, Su Z, Turk BE, Chen S, Chang YH, Wu Z, Biemann K, and Liu JO (1997) Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1740 and ovalicin. Chem Biol 4:461-471.
11. Habas R, Kato Y, and He X (2001) Wnt/frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1. Cell 107:843-854.
12. Hahnfeldt P, Panigrahy D, Folkman J, and Hlatky L (1999) Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response and postvascular dormancy. Cancer Res 59:4770-4775.
13. Huang Y, Liu Z, Huang H, Liu H, and Li L (2005) Effects of mycophenolic acid on endothelial cells. Int Immunopharmacol 5:1029-1039.
14. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, and Folkman J (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348:555-557.
15. Ji Y, Gu J, Makhov AM, Griffith JD, and Mitchell BS (2006) Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic acid by GTP. J Biol Chem 281:206-212.
16. Katanaev VL, Ponzielli R, Sémériva M, and Tomlinson A (2005) Trimeric G protein-dependent frizzled signaling in Drosophila. Cell 120:111-122.
17. Khan SH, Moritsugu J, and Wahl GM (2000) Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption and ribonucleotide depletion. Proc Natl Acad Sci USA 97:3266-3271.
18. Kicska GA, Tyler PC, Evans GB, Furneaux RH, Kim K, and Schramm VL (2002) Transition state analogue inhibitors of purine nucleoside phosphorylase from Plasmodium falciparum. J Biol Chem 277:3219-3225.
19. Liu S, Widom J, Kemp CW, Crews CM, and Clardy J (1998a) Structure of human methionine aminopeptidase-2 complexed with fumagillin. Science 282:1324-1327.
20. Liu Y, Bohn SA, and Sherley JL (1998b) Inosine-5′-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation. Mol Biol Cell 9:15-28.
21. Mann GJ, Musgrove EA, Fox RM, and Thelander L (1988) Ribonuclease reductase M1 subunit in cellular proliferation, quiescence, and differentiation. Cancer Res 48:5151-5156.
22. Nahari D, Satchi-Fainaro R, Chen M, Mitchell I, Task LB, Liu Z, Kihneman J, Carroll AB, Terada LS, and Nwariaku FE (2007) Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer. Mol Cancer Ther 6:1329-1337.
23. Nowak JZ (2006) Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 58:353-363.
24. Pandya NM, Dhalla NS, and Santani DD (2006) Angiogenesis- a new target for future therapy. Vascul Pharmacol 44:265-274.
25. Satchi-Fainaro R, Mamluk R, Wang L, Short SM, Nagy JA, Feng D, Dvorak AM, Dvorak HF, Puder M, Mukhopadhyay D, et al. (2005) Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell 7:251-261.
26. Schreiber E, Matthias P, Müller MM, and Schaffner W (1989) Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res 17:6419.
27. Senda M, DeLustro B, Eugui E, and Natsumeda Y (1995) Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunnosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells. Transplantation 60:1143-1148.
28. Sim BK (1998) Angiostatin and endostatin: endothelial cell-specific endogenous inhibitors of angiogenesis and tumor growth. Angiogenesis 2:37-48.
29. Sin N, Meng L, Wang MQ, Wen JJ, Bornmann WG, and Crews CM (1997) The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci USA 94:6099-6103.
30. Sokoloski JA and Sartorelli AC (1985) Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid on glycoprotein metabolism. Mol Pharmacol 28:567-573.
31. Szekanecz Z, Gáspár L, and Koch AE (2005) Angiogenesis in rheumatoid arthritis. Front Biosci 10:1739-1753.
32. Takechi A, Uozumi T, Kawamoto K, Ito A, Kurisu K, and Sudo K (1994) Inhibitory effect of TNP-470, a new anti-angiogenic agent, on estrogen induced rat pituitary tumors. Anticancer Res 14:157-162. (Pubitemid 24132105)
33. Taylor WR, Agarwal ML, Agarwal A, Stacey DW, and Stark GR (1999) p53 inhibits entry into mitosis when DNA synthesis is blocked. Oncogene 18:283-295.
34. Yalowitz JA and Jayaram HN (2000) Molecular targets of guanine nucleotides in differentiation, proliferation and apoptosis. Anticancer Res 20:2329-2338.
35. Yeh JR, Ju R, Brdlik CM, Zhang W, Zhang Y, Matyskiela ME, Shotwell JD, and Crews CM (2006) Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest. Proc Natl Acad Sci USA 103:10379-10384.
36. CIP/WAF for endothelial cell growth arrest. Proc Natl Acad Sci USA 97:12782-12787.
37. Zhang Y, Griffith EC, Sage J, Jacks T, and Liu JO (2000) Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1. Proc Natl Acad Sci USA 97:6427-6432.
38. Zhang Y, Yeh JR, Mara A, Ju R, Hines JF, Cirone P, Griesbach HL, Schneider I, Slusarski DC, Holley SA, et al. (2006) A chemical and genetic approach to the mode of action of fumagillin. Chem Biol 13:1001-1009.